<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The measurement of erythrocyte <z:chebi fb="0" ids="28783">zinc protoporphyrin</z:chebi> (ZPP) with a hematofluorometer is known to be a simple and cost-effective method to screen <z:e sem="disease" ids="C0240066" disease_type="Disease or Syndrome" abbrv="">iron deficiency</z:e> and lead poisoning </plain></SENT>
<SENT sid="1" pm="."><plain>We measured ZPP on blood samples from 201 children suffering from various diseases, which revealed that ZPP has better sensitivity and specificity for identifying <z:e sem="disease" ids="C0240066" disease_type="Disease or Syndrome" abbrv="">iron deficiency</z:e> than serum ferritin and percent transferrin saturation </plain></SENT>
<SENT sid="2" pm="."><plain>ZPP levels in various <z:hpo ids='HP_0001903'>anemias</z:hpo> were also measured </plain></SENT>
<SENT sid="3" pm="."><plain>ZPP rose markedly (&gt; 200 mumol/mol <z:chebi fb="4" ids="30413">heme</z:chebi>) in untreated <z:hpo ids='HP_0001891'>iron deficiency anemia</z:hpo> and returned to <z:mpath ids='MPATH_458'>normal</z:mpath> in 3-4 months since the initiation of iron therapy </plain></SENT>
<SENT sid="4" pm="."><plain>Moderate elevation of ZPP was observed in <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> (at <z:hpo ids='HP_0003674'>onset</z:hpo> and during induction therapy), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and some other anemic conditions </plain></SENT>
<SENT sid="5" pm="."><plain>These findings suggest that erythrocyte ferrochelatase may be unexpectedly affected in <z:hpo ids='HP_0001903'>anemias</z:hpo> even except lead poisoning </plain></SENT>
</text></document>